Jan. 9, 2025 — Researchers have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used clinical risk factors. This could help ...

and active targeting features demonstrate great potential for siRNA delivery. Lipid nanoparticle-based siRNA delivery enables us to fulfill the vision of personalized medicine.

We used lipid nanoparticles to deliver mRNA and siRNA to human PCa cells to evaluate our technique's ability to both restore the lost PTEN and silence the overexpressed AR. Our strategy could also ...

It is an antisense RNAi oligonucleotide delivered through lipid-nanoparticles and is administered intravenously. Nitto BioPharma, a subsidiary of Nitto Denko Corp, is a biopharmaceutical company that ...

Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) offer high-resolution images for nanoparticle morphology (fixed samples─in vitro imaging) but encounter challenges with ...

(“Altamira” or the “Company”) (OTCQB:CYTOF), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, today announced that its nanoparticle-based ...

Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada Michael Smith Laboratories, University of British Columbia, Vancouver, ...

Published in Nano Biomedicine and Engineering, the study introduces AS1411-siRNA lipid nanoparticles (As@LNPs) as a promising tool for safer and more effective cancer therapies. Gastric cancer ...